130 related articles for article (PubMed ID: 8008162)
1. In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Hall WA; Myklebust A; Godal A; Nesland JM; Fodstad O
Neurosurgery; 1994 Apr; 34(4):649-55; discussion 655-6. PubMed ID: 8008162
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.
Bigner DD; Archer GE; McLendon RE; Friedman HS; Fuchs HE; Pai LH; Herndon JE; Pastan IH
Clin Cancer Res; 1995 Dec; 1(12):1545-55. PubMed ID: 9815955
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
Myklebust AT; Godal A; Fodstad O
Cancer Res; 1994 Apr; 54(8):2146-50. PubMed ID: 8174121
[TBL] [Abstract][Full Text] [Related]
4. Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
Archer GE; Sampson JH; Lorimer IA; McLendon RE; Kuan CT; Friedman AH; Friedman HS; Pastan IH; Bigner DD
Clin Cancer Res; 1999 Sep; 5(9):2646-52. PubMed ID: 10499644
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
Engebraaten O; Hjortland GO; Juell S; Hirschberg H; Fodstad O
Int J Cancer; 2002 Feb; 97(6):846-52. PubMed ID: 11857366
[TBL] [Abstract][Full Text] [Related]
6. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
Debinski W; Pastan I
Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme.
Hall WA; Godal A; Juell S; Fodstad O
J Neurosurg; 1992 May; 76(5):838-44. PubMed ID: 1314294
[TBL] [Abstract][Full Text] [Related]
8. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
9. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer.
FitzGerald DJ; Willingham MC; Pastan I
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6627-30. PubMed ID: 3018739
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.
Pastan IH; Archer GE; McLendon RE; Friedman HS; Fuchs HE; Wang QC; Pai LH; Herndon J; Bigner DD
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2765-9. PubMed ID: 7708720
[TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.
Pearson JW; FitzGerald DJ; Willingham MC; Wiltrout RH; Pastan I; Longo DL
Cancer Res; 1989 Jul; 49(13):3562-7. PubMed ID: 2499420
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3358-62. PubMed ID: 2014255
[TBL] [Abstract][Full Text] [Related]
14. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
Engebraaten O; Sivam G; Juell S; Fodstad O
Int J Cancer; 2000 Dec; 88(6):970-6. PubMed ID: 11093823
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
Reiter Y; Kreitman RJ; Brinkmann U; Pastan I
Int J Cancer; 1994 Jul; 58(1):142-9. PubMed ID: 8014011
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
Hjortland GO; Garman-Vik SS; Juell S; Olsen OE; Hirschberg H; Fodstad O; Engebraaten O
J Neurosurg; 2004 Feb; 100(2):320-7. PubMed ID: 15086240
[TBL] [Abstract][Full Text] [Related]
17. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.
Benhar I; Reiter Y; Pai LH; Pastan I
Int J Cancer; 1995 Jul; 62(3):351-5. PubMed ID: 7628878
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
[TBL] [Abstract][Full Text] [Related]
19. Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.
Wang G; Kumar A; Ding W; Korangath P; Bera T; Wei J; Pai P; Gabrielson K; Pastan I; Sukumar S
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2200200119. PubMed ID: 35675429
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S
J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
